Alcon Inc., CH0432492467

Alcon stock pre-market at EUR 57.34: plus 0.14 percent

Published on 10/01/2026 at 08:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Alcon stock was at EUR 57.34 pre-market at 8:23 a.m. CEST on October 1, 2026, up 0.14 percent versus the prior close. The company recently announced a Canadian product launch.

Black and white photojournalism style. Ophthalmologist using slit-lamp biomicroscope to examine patient seated in optometry chair, strong chiaroscuro contrast, documentary grain, intimate clinical moment captured in wide horizontal frame
Alcon CH0432492467: Schwarz Weiß Fotografie eines Augenarztes mit Spaltlampe und Patient im Untersuchungsstuhl, Illustration mit AI erstellt.

Alcon stock was at EUR 57.34 pre-market at 8:23 a.m. CEST on October 1, 2026, according to Lang & Schwarz. The price was up 0.14 percent versus the Lang & Schwarz prior close of EUR 57.26 on September 30, 2026.

Pre-market pricing

Lang & Schwarz listed a bid of EUR 57.22 and an ask of EUR 57.46. The further course from the Xetra open at 9:00 a.m. CET/CEST is shown by the continuously updated real-time quote of Alcon stock.

Previous close

The Lang & Schwarz prior close was EUR 57.26 on September 30, 2026. The current euro indication and the prior close refer to the Lang & Schwarz market data.

Recent product launch

In a September 28, 2026 company announcement carried by the Financial Times, Alcon said it launched Systane PRO Preservative-Free in Canada. The company described the eye drop as a preservative-free, triple-action formula and said it provides up to 12 hours of dry-eye symptom relief. The announcement identified the product as the latest addition to Alcon’s Systane portfolio.

Surgical microscope rollout

In a September 3, 2026 release distributed through Business Wire, Alcon announced the initial commercial launch of its UNITY M ophthalmic microscope in select markets, including the United States and Japan, followed by Europe. The company said inventory began shipping in September and that the system had received regulatory approvals in several markets, including the United States and Europe.

Disclaimer...

en | CH0432492467 | ALCON INC. | boerse | 70208335 | bgmi